Goodwin

Sarah Solomon

Deals
5
Latest
Aug 2026
Most deals in
Biotech

Firm

  • Goodwin Law firm · 2026 · 5 deals
Deals by year
Sarah Solomon: deals by year0520252026 YTD: 4 M&A2026 YTD: 1 Equity raisings52026 YTDM&AEquity raisings

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals Sarah Solomon was named on, most recent first
Aug 2026 Merida Biosciences –Eli Lilly and CompanyAcquisitionLegal adviser to Merida Biosciences (target)Announced2,875.0Biotech+1Eli Lilly and Company acquisition of Merida Biosciences
Jun 2026 Parabilis Medicines ––PlacementLegal adviser to the issuerCompleted75.0Biotech+1Parabilis Medicines placement
Apr 2026 Kelonia Therapeutics –Eli Lilly and CompanyAcquisitionLegal adviser to Kelonia Therapeutics (target)Announced7,000.0Biotech+2Eli Lilly and Company acquisition of Kelonia Therapeutics
Apr 2026 Tubulis EQT Life Sciences (LSP 7 fund)Gilead SciencesAcquisitionLegal adviser to Tubulis (target)Announced3,150.0Biotech+2Gilead Sciences acquisition of Tubulis
Mar 2026 Pikavation SynnovationNovartisAcquisitionLegal adviser to Synnovation Therapeutics (seller)Announced2,000.0Biotech+2Novartis acquisition of Pikavation

Deals where Sarah Solomon is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.